304 related articles for article (PubMed ID: 23093658)
1. Vegfa protects the glomerular microvasculature in diabetes.
Sivaskandarajah GA; Jeansson M; Maezawa Y; Eremina V; Baelde HJ; Quaggin SE
Diabetes; 2012 Nov; 61(11):2958-66. PubMed ID: 23093658
[TBL] [Abstract][Full Text] [Related]
2. Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.
Zhong F; Chen H; Wei C; Zhang W; Li Z; Jain MK; Chuang PY; Chen H; Wang Y; Mallipattu SK; He JC
Kidney Int; 2015 Feb; 87(2):382-95. PubMed ID: 25185079
[TBL] [Abstract][Full Text] [Related]
3. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
[TBL] [Abstract][Full Text] [Related]
4. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
5. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
6. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
[TBL] [Abstract][Full Text] [Related]
7. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
8. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
[TBL] [Abstract][Full Text] [Related]
11. Endoglin Mediates Vascular Endothelial Growth Factor-A-Induced Endothelial Cell Activation by Regulating Akt Signaling.
Bus P; Gerrits T; Heemskerk SAC; Zandbergen M; Wolterbeek R; Bruijn JA; Baelde HJ; Scharpfenecker M
Am J Pathol; 2018 Dec; 188(12):2924-2935. PubMed ID: 30248336
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
13. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
[TBL] [Abstract][Full Text] [Related]
14. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
15. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.
Gödel M; Hartleben B; Herbach N; Liu S; Zschiedrich S; Lu S; Debreczeni-Mór A; Lindenmeyer MT; Rastaldi MP; Hartleben G; Wiech T; Fornoni A; Nelson RG; Kretzler M; Wanke R; Pavenstädt H; Kerjaschki D; Cohen CD; Hall MN; Rüegg MA; Inoki K; Walz G; Huber TB
J Clin Invest; 2011 Jun; 121(6):2197-209. PubMed ID: 21606591
[TBL] [Abstract][Full Text] [Related]
16. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
17. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
18. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
19. Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.
Kim DK; Nam BY; Li JJ; Park JT; Lee SH; Kim DH; Kim JY; Kang HY; Han SH; Yoo TH; Han DS; Kang SW
Diabetologia; 2012 Apr; 55(4):1205-17. PubMed ID: 22311416
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
Hinamoto N; Maeshima Y; Yamasaki H; Nasu T; Saito D; Watatani H; Ujike H; Tanabe K; Masuda K; Arata Y; Sugiyama H; Sato Y; Makino H
PLoS One; 2014; 9(9):e107934. PubMed ID: 25255225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
